Latest News from: University of Maryland Medical Center

Filters close

Not for public release

This news release is embargoed until 7-Aug-2023 2:05 PM EDT Released to reporters: 7-Aug-2023 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 2:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 9-Jul-2013 2:45 PM EDT
Experts Available to Comment on New Guidelines on Aromatase Inhibitors for Breast Cancer Prevention
University of Maryland Medical Center

The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women. Two breast cancer experts at the University of Maryland Greenebaum Cancer Center are available to comment on the new guideline.


Showing results 1 – 17 of 17


close
0.1279